BASSI, Cristian
 Distribuzione geografica
Continente #
NA - Nord America 2.267
EU - Europa 750
AS - Asia 507
AF - Africa 1
OC - Oceania 1
Totale 3.526
Nazione #
US - Stati Uniti d'America 2.257
IT - Italia 235
CN - Cina 212
PL - Polonia 184
SG - Singapore 144
TR - Turchia 77
DE - Germania 70
GB - Regno Unito 67
UA - Ucraina 54
SE - Svezia 52
ID - Indonesia 40
FI - Finlandia 27
BE - Belgio 26
VN - Vietnam 17
CA - Canada 10
FR - Francia 7
LT - Lituania 6
CZ - Repubblica Ceca 5
HK - Hong Kong 5
IE - Irlanda 4
IR - Iran 3
KZ - Kazakistan 3
TW - Taiwan 3
AT - Austria 2
HU - Ungheria 2
IN - India 2
RO - Romania 2
AL - Albania 1
AU - Australia 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
LU - Lussemburgo 1
LV - Lettonia 1
NL - Olanda 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.526
Città #
Fairfield 328
Woodbridge 267
Warsaw 184
Chandler 171
Ashburn 162
Ann Arbor 160
Houston 149
Santa Clara 132
Seattle 131
Singapore 122
Cambridge 108
Ferrara 107
Wilmington 104
Jacksonville 79
Beijing 69
New York 47
Izmir 42
Jakarta 40
Milan 36
Nanjing 33
Shanghai 33
Princeton 29
Brussels 26
San Diego 23
Boardman 18
Addison 16
Bremen 16
Dong Ket 15
Los Angeles 14
Helsinki 12
London 11
Shenyang 10
Bologna 9
Falls Church 9
Mountain View 9
Munich 9
Nanchang 9
Redwood City 9
Washington 9
Tianjin 8
Hebei 7
Toronto 7
Monte San Pietro 6
Brno 5
Changsha 5
Ferrara di Monte Baldo 5
Frankfurt am Main 5
Dublin 4
Hong Kong 4
Ningbo 4
Sant'Elpidio a Mare 4
Dearborn 3
Des Moines 3
Hangzhou 3
Jiaxing 3
Jinan 3
Kunming 3
Ottawa 3
Taipei 3
Acton 2
Almaty 2
Ardabil 2
Augusta 2
Bari 2
Bolzano 2
Celldömölk 2
Florence 2
Focsani 2
Hanoi 2
Lappeenranta 2
L’Aquila 2
Modena 2
Orange 2
Parma 2
Redmond 2
San Giorgio Di Piano 2
Stockholm 2
Trieste 2
Vienna 2
Zhengzhou 2
Agna 1
Amsterdam 1
Anzola Dell'emilia 1
Arcene 1
Basel 1
Berlin 1
Brescia 1
Brookline 1
Central District 1
Changchun 1
Chicago 1
Columbus 1
Dalian 1
Edinburgh 1
Greenwich 1
Guangzhou 1
Hounslow 1
Hull 1
Islington 1
Lanzhou 1
Totale 2.907
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 192
Absolute quantification of cell-free microRNAs in cancer patients 191
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 170
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 169
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 155
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 155
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 150
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 146
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 138
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 136
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 136
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 134
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 129
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 128
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 125
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 123
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 116
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 113
Interspecies gene name extrapolation - A new approach 108
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 105
null 89
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 86
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 84
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 84
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 77
Defining the oral microbiome by whole-genome sequencing and resistome analysis: The complexity of the healthy picture 71
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 68
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 54
Detection of disease-causing mutations in prostate cancer by NGS sequencing 44
Novel Virus Identification through Metagenomics: A Systematic Review 37
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 27
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 27
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 21
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 21
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 17
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 6
Totale 3.632
Categoria #
all - tutte 18.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020401 0 0 0 0 0 72 69 65 67 61 29 38
2020/2021721 41 69 48 63 38 64 40 54 29 157 80 38
2021/2022359 15 22 31 12 21 19 38 17 12 31 41 100
2022/2023398 35 40 24 53 54 61 39 24 35 6 17 10
2023/2024286 17 25 17 8 35 76 13 12 4 8 6 65
2024/2025425 27 26 86 69 129 88 0 0 0 0 0 0
Totale 3.632